2m 2m 2m 2m 2m 2m 2m
AUTONOMIX (AMIX)
NASDAQ
$0.39-$0.02 (-5.55%)
Price as of Jun 03, 2026 7:39 PM EDT- $4.6MMarket Cap
- -74.32%1-Year Change
- Medical DevicesIndustry
AUTONOMIX (AMIX)
$0.39-$0.02 (-5.55%)
Annual
Quarterly
03/31/2025 | 03/31/2024 | ||
|---|---|---|---|
Income Statement | |||
Total Operating Revenue | 0 N/A | 0 N/A | |
Cost of Revenue | N/A N/A | N/A N/A | |
Gross Profit | 0 N/A | 0 N/A | |
Sales and Marketing Expense | 100,000 -94.12% | 1.7M N/A | |
Research and Development Expense | -4.7M +112.36% | -2.2M N/A | |
Depreciation and Amortization Expense | N/A N/A | 81,000 N/A | |
Total Operating Expenses | 11.6M -3.67% | 12.0M N/A | |
Operating Profit | -11.6M -3.67% | -12.0M N/A | |
Interest Income | 354,000 +178.74% | 127,000 N/A | |
Interest Expense | -200,000 +100.00% | -100,000 N/A | |
Interest Income and Expense and Net | 154,000 +470.37% | 27,000 N/A | |
Total Nonoperating Income and Expense | 178,000 +105.24% | -3.4M N/A | |
Income before Taxes | -11.4M -26.03% | -15.4M N/A | |
Income Taxes | 0 N/A | 0 N/A | |
Extraordinary Items | N/A N/A | N/A N/A | |
Net Income | -11.4M -26.03% | -15.4M N/A | |
Net Income from Continuing Operations Applicable to Common | -11.4M -26.03% | -15.4M N/A | |
Basic EPS and Net Income | -6.46 +515.24% | -1.05 N/A | |
Diluted EPS and Net Income | -6.46 +515.24% | -1.05 N/A | |
Basic Weighted Average Shares | 1.8M -87.92% | 14.6M N/A | |
Diluted Weighted Average Shares | 1.8M -87.92% | 14.6M N/A | |
Balance Sheet | |||
Cash and Cash Equivalents | 9.1M +6.13% | 8.6M N/A | |
Short-Term Investments | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 9.1M +6.13% | 8.6M N/A | |
Total Current Assets | 9.6M +2.32% | 9.4M N/A | |
Accumulated Depreciation | N/A N/A | N/A N/A | |
Property and Plant and Equipment and Net | 21,000 +31.25% | 16,000 N/A | |
Total Long-Term Assets | 197,000 +1,131.25% | 16,000 N/A | |
Total Assets | 9.8M +4.24% | 9.4M N/A | |
Income Taxes Payable | N/A N/A | N/A N/A | |
Total Short-Term Debt | N/A N/A | N/A N/A | |
Total Current Liabilities | 1.7M +119.69% | 777,000 N/A | |
Total Long-Term Debt | 0 -100.00% | 1.0M N/A | |
Total Long-Term Liabilities | 0 -100.00% | 1.0M N/A | |
Total Liabilities | 1.7M -4.05% | 1.8M N/A | |
Retained Earnings | -50.4M +29.28% | -39.0M N/A | |
Total Stockholders Equity | 8.1M +6.17% | 7.6M N/A | |
Total Shares Outstanding | 2.5M -86.75% | 18.8M N/A | |
Cash Flow | |||
Cash from Operating Activities | -8.3M +24.85% | -6.6M N/A | |
Capital Expenditures | N/A N/A | 19,000 N/A | |
Cash from Investing Activities | N/A N/A | -19,000 N/A | |
Dividends Paid | N/A N/A | N/A N/A | |
Cash from Financing Activities | N/A N/A | 14.4M N/A | |
Financials Ratio | |||
Gross Margin | N/A N/A | N/A N/A | |
Operating Margin | N/A N/A | N/A N/A | |
Return on Assets | -118.77% N/A | N/A N/A | |
Return on Equity | -145.10% N/A | N/A N/A | |
Revenue Growth | N/A N/A | N/A N/A | |
Current Ratio | 5.63 N/A | N/A N/A | |
Cash Ratio | 5.35 N/A | N/A N/A | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow